Kamelija Zarkovic Selected Research

4-hydroxy-2-nonenal (4-hydroxynonenal)

10/2023	Relationship between 4-Hydroxynonenal (4-HNE) as Systemic Biomarker of Lipid Peroxidation and Metabolomic Profiling of Patients with Prostate Cancer.
1/2022	Post-mortem Findings of Inflammatory Cells and the Association of 4-Hydroxynonenal with Systemic Vascular and Oxidative Stress in Lethal COVID-19.
1/2017	4-hydroxynonenal causes impairment of human subcutaneous adipogenesis and induction of adipocyte insulin resistance.
1/2010	Interval hypoxic training in complex treatment of Helicobacter pylori-associated peptic ulcer disease.
11/2009	Distribution of 4-hydroxynonenal-protein conjugates as a marker of lipid peroxidation and parameter of malignancy in astrocytic and ependymal tumors of the brain.
2/2009	Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: prevention by oxygen-regulated protein 150 expression.
3/2008	The distribution of 4-hydroxynonenal-modified proteins in gastric mucosa of duodenal peptic ulcer patients.
8/2003	4-hydroxynonenal and neurodegenerative diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kamelija Zarkovic Research Topics

Disease

10	Neoplasms (Cancer) 10/2023 - 03/2003
4	Atherosclerosis 10/2017 - 02/2009
3	Glioblastoma (Glioblastoma Multiforme) 03/2013 - 06/2005
3	Neoplasm Metastasis (Metastasis) 03/2013 - 03/2003
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2011 - 02/2010
3	Ulcer 09/2011 - 02/2010
2	Obesity 01/2017 - 10/2014
2	Insulin Resistance 01/2017 - 01/2017
2	Body Weight (Weight, Body) 10/2014 - 05/2009
2	Hepatic Encephalopathy 09/2011 - 03/2011
2	Brain Edema (Cerebral Edema) 09/2011 - 03/2011
2	Wounds and Injuries (Trauma) 09/2011 - 03/2011
2	Carcinogenesis 05/2010 - 06/2006
2	Carcinoma (Carcinomatosis) 05/2010 - 06/2006
2	Astrocytoma (Pilocytic Astrocytoma) 09/2008 - 01/2005
1	Prostatic Neoplasms (Prostate Cancer) 10/2023
1	COVID-19 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Hypothyroidism 01/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Liver Neoplasms (Liver Cancer) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Glucose Intolerance 10/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2014
1	Arthralgia (Joint Pain) 11/2011
1	Weight Gain 09/2011
1	Weight Loss (Weight Reduction) 09/2011
1	Hepatomegaly 09/2011
1	Brain Diseases (Brain Disorder) 03/2011
1	Margins of Excision 05/2010
1	Colonic Neoplasms (Colon Cancer) 05/2010
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2010
1	Crush Injuries 02/2010
1	Hepatitis 02/2010
1	Inflammation (Inflammations) 01/2010
1	Brain Injuries (Brain Injury) 11/2009
1	Hyperplasia 02/2009
1	Peptic Ulcer (Peptic Ulcers) 03/2008
1	Melanoma (Melanoma, Malignant) 02/2007
1	Adenoma (Adenomas) 06/2006
1	Pick Disease of the Brain (Pick's Disease) 08/2003
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2003
1	Alzheimer Disease (Alzheimer's Disease) 08/2003
1	Huntington Disease (Huntington's Disease) 08/2003
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2003

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2017 - 08/2003
8	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 10/2023 - 08/2003
4	Monoclonal AntibodiesIBA 10/2023 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 05/2010
3	Peptides (Polypeptides)IBA 09/2011 - 02/2010
3	BPC 157IBA 09/2011 - 02/2010
2	AntioxidantsIBA 10/2023 - 10/2014
2	Insulin (Novolin)FDA Link 01/2017 - 01/2017
2	Acrolein (Aqualin)IBA 05/2010 - 06/2006
2	Histidine (L-Histidine)FDA Link 03/2008 - 01/2005
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2023
1	Linoleic Acid (Linoleate)IBA 10/2023
1	Blood Proteins (Serum Proteins)IBA 10/2023
1	NivolumabIBA 01/2018
1	Cardiolipins (Cardiolipin)IBA 01/2017
1	AldehydesIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	StaurosporineIBA 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	LipidsIBA 01/2017
1	ElastinIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 10/2014
1	Xanthine OxidaseIBA 10/2014
1	acetovanillone (apocynin)IBA 10/2014
1	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2014
1	Allopurinol (Remid)FDA LinkGeneric 10/2014
1	mitoquinoneIBA 10/2014
1	Temozolomide (Temodar)FDA LinkGeneric 03/2013
1	Drinking WaterIBA 09/2011
1	Ibuprofen (Motrin)FDA LinkGeneric 09/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2011
1	Diclofenac (SR 38)FDA LinkGeneric 03/2011
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2011
1	BilirubinIBA 03/2011
1	Alanine Transaminase (SGPT)IBA 03/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2010
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 05/2009
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2009
1	OsteopontinIBA 09/2008
1	Glycoproteins (Glycoprotein)IBA 09/2008
1	sephadexIBA 02/2007
1	EndoglinIBA 06/2005
1	ParaffinIBA 01/2005
1	Hematoxylin (Haematoxylon)IBA 01/2005
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2005

Therapy/Procedure

2	Therapeutics 03/2013 - 03/2003
1	Drug Therapy (Chemotherapy) 03/2013
1	Adjuvant Radiotherapy 03/2013
1	Adjuvant Chemoradiotherapy 03/2013
1	Conservative Treatment 11/2011
1	Prostatectomy (Retropubic Prostatectomy) 05/2010
1	Life Support Care 03/2003